Free Trial

Janus Henderson Group PLC Purchases New Shares in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

Janus Henderson Group PLC purchased a new position in shares of Genpact Limited (NYSE:G - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 74,300 shares of the business services provider's stock, valued at approximately $3,192,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of G. Coppell Advisory Solutions LLC raised its stake in shares of Genpact by 529.5% during the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after purchasing an additional 503 shares during the last quarter. SRH Advisors LLC purchased a new position in Genpact during the 4th quarter worth $26,000. Atlas Capital Advisors Inc. lifted its stake in shares of Genpact by 55.8% in the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after acquiring an additional 216 shares during the period. Manchester Capital Management LLC acquired a new stake in shares of Genpact in the 4th quarter worth $38,000. Finally, GeoWealth Management LLC boosted its holdings in shares of Genpact by 199.0% in the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock valued at $38,000 after acquiring an additional 583 shares in the last quarter. 96.03% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on G shares. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and increased their price target for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and boosted their target price for the stock from $45.00 to $60.00 in a research report on Friday, February 7th. Needham & Company LLC reduced their price target on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a report on Thursday, May 8th. Robert W. Baird decreased their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating on the stock in a research note on Thursday, May 8th. Finally, Mizuho upped their price objective on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $50.71.

View Our Latest Report on G

Genpact Stock Performance

G opened at $44.08 on Tuesday. Genpact Limited has a 1-year low of $30.38 and a 1-year high of $56.76. The stock has a market cap of $7.71 billion, a P/E ratio of 15.52, a P/E/G ratio of 1.84 and a beta of 1.02. The stock's 50 day simple moving average is $47.92 and its 200 day simple moving average is $47.30. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85.

Genpact (NYSE:G - Get Free Report) last posted its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. The company had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.21 billion. Genpact had a return on equity of 22.50% and a net margin of 10.77%. Genpact's revenue was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.73 earnings per share. As a group, equities analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the completion of the transaction, the chief executive officer now owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Nicholas C. Gangestad bought 2,000 shares of the stock in a transaction on Tuesday, May 13th. The stock was purchased at an average cost of $43.97 per share, with a total value of $87,940.00. Following the completion of the purchase, the director now directly owns 2,000 shares in the company, valued at $87,940. This trade represents a ∞ increase in their position. The disclosure for this purchase can be found here. 3.07% of the stock is currently owned by company insiders.

Genpact Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Institutional Ownership by Quarter for Genpact (NYSE:G)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines